E. Ioachim

2.8k total citations
79 papers, 1.7k citations indexed

About

E. Ioachim is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, E. Ioachim has authored 79 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 28 papers in Molecular Biology and 21 papers in Surgery. Recurrent topics in E. Ioachim's work include Bladder and Urothelial Cancer Treatments (12 papers), Proteoglycans and glycosaminoglycans research (10 papers) and Cancer-related Molecular Pathways (9 papers). E. Ioachim is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Proteoglycans and glycosaminoglycans research (10 papers) and Cancer-related Molecular Pathways (9 papers). E. Ioachim collaborates with scholars based in Greece, United States and United Kingdom. E. Ioachim's co-authors include Niki J. Agnantis, Antonia Charchanti, Elena Tsanou, Evangelos Briasoulis, Vasilios Karavasilis, Nicholas Pavlidis, Vasiliki Malamou‐Mitsi, Dimitrios Arvanitis, Maria Stefaniotou and A. Goussia and has published in prestigious journals such as European Journal of Cancer, The Journal of Pathology and Journal of Clinical Pathology.

In The Last Decade

E. Ioachim

79 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Ioachim Greece 24 674 492 375 317 269 79 1.7k
Douglas Armellino United States 15 1.3k 2.0× 738 1.5× 99 0.3× 401 1.3× 444 1.7× 18 2.3k
R. Kath Germany 18 433 0.6× 454 0.9× 187 0.5× 109 0.3× 94 0.3× 55 1.3k
Niranjan Awasthi United States 25 889 1.3× 703 1.4× 211 0.6× 338 1.1× 191 0.7× 65 1.9k
William Benedict United States 6 912 1.4× 267 0.5× 145 0.4× 295 0.9× 347 1.3× 9 1.7k
Bryan K. McCune United States 17 1.1k 1.6× 557 1.1× 145 0.4× 253 0.8× 197 0.7× 26 2.0k
Arnold I. Coffer United Kingdom 15 1.0k 1.5× 398 0.8× 393 1.0× 204 0.6× 100 0.4× 32 1.9k
Michael Fannon United States 13 809 1.2× 276 0.6× 153 0.4× 273 0.9× 90 0.3× 22 1.3k
Jennifer A. Doll United States 21 921 1.4× 363 0.7× 109 0.3× 371 1.2× 47 0.2× 29 1.6k
E M Rosen United States 28 1.8k 2.7× 784 1.6× 678 1.8× 408 1.3× 188 0.7× 38 3.5k
Liliana Guédez United States 18 810 1.2× 663 1.3× 120 0.3× 921 2.9× 90 0.3× 22 1.8k

Countries citing papers authored by E. Ioachim

Since Specialization
Citations

This map shows the geographic impact of E. Ioachim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ioachim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ioachim more than expected).

Fields of papers citing papers by E. Ioachim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ioachim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ioachim. The network helps show where E. Ioachim may publish in the future.

Co-authorship network of co-authors of E. Ioachim

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ioachim. A scholar is included among the top collaborators of E. Ioachim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ioachim. E. Ioachim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ioachim, E., et al.. (2006). Hypoxia-Inducible Factors HIF-1α and HIF-2α Expression in Bladder Cancer and Their Associations with Other Angiogenesis-Related Proteins. Urologia Internationalis. 77(3). 255–263. 30 indexed citations
2.
Tsanou, Elena, et al.. (2006). Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1. Eye. 21(8). 1095–1101. 99 indexed citations
3.
Κατσάνος, Κωνσταντίνος, et al.. (2005). Inflammatory bowel disease-related dysplasia and cancer: A referral center study in northwestern Greece. European Journal of Internal Medicine. 16(3). 170–175. 12 indexed citations
4.
Mitselou, Antigony, E. Ioachim, Theodore Vougiouklakis, et al.. (2004). Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.. PubMed. 17(5). 469–77. 16 indexed citations
5.
Ioachim, E., et al.. (2003). Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.. PubMed. 22(6A). 3383–8. 17 indexed citations
6.
Charalabopoulos, K., et al.. (2003). Inhibition of Benzo(a)pyrene-Induced Carcinogenesis by Vitamin C Alone and by Vitamin C/Vitamin E and Selenium/Glutathione. Biological Trace Element Research. 93(1-3). 201–212. 6 indexed citations
7.
Ioachim, E., Michael Michail, David Price, et al.. (2003). A fatal case of sclerosing mesenteritis. Digestive and Liver Disease. 36(2). 153–156. 13 indexed citations
9.
Charalabopoulos, K., et al.. (2003). Lung, Pleural and Colon Actinomycosis in an Immunocompromised Patient: A Rare Form of Presentation. Chemotherapy. 49(4). 209–211. 8 indexed citations
10.
Baltogiannis, D., Christos Kalogeropoulos, E. Ioachim, et al.. (2003). Orbital Metastasis from Prostatic Carcinoma. Urologia Internationalis. 70(3). 219–222. 13 indexed citations
11.
Stavropoulos, Nikolaos, et al.. (2003). Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.. PubMed. 22(6B). 3759–64. 34 indexed citations
13.
Ioachim, E., et al.. (2001). Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.. PubMed. 20(6B). 4221–5. 21 indexed citations
14.
Ioachim, E., et al.. (2001). Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices.. PubMed. 21(3B). 1757–61. 12 indexed citations
16.
Ioachim, E., A. Goussia, & Niki J. Agnantis. (1999). Glycoprotein CD44 expression in colorectal neoplasms. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 434(1). 45–50. 10 indexed citations
17.
Ioachim, E., et al.. (1999). Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.. PubMed. 19(3A). 2133–9. 16 indexed citations
18.
Ioachim, E., et al.. (1998). Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.. PubMed. 18(3A). 1665–70. 17 indexed citations
19.
Malizos, K.N., et al.. (1998). Pathologic fracture of the scaphoid due to enchondroma: Treatment with vascularized bone grafting report of a case. The Journal Of Hand Surgery. 23(2). 334–337. 13 indexed citations
20.
Ioachim, E., et al.. (1996). The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.. PubMed. 16(5B). 3141–7. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026